Purpose: We set out to characterize the mechanical effects of myeloperoxidase (MPO) in 2 isolated left ventricular human cardiomyocytes. Oxidative myofilament protein modifications 3 (sulfhydryl (SH) group oxidation and carbonylation) induced by the peroxidase and 4 chlorinating activities of MPO were additionally identified. The specificity of the MPO-5 evoked functional alterations was tested with an MPO inhibitor (MPO-I) and the antioxidant 6 amino acid Met. 7
Introduction 1
Oxidative stress-related myofilament protein alterations have been shown to play key roles in 2 the impaired cardiomyocyte contractility in response to myocardial inflammation, ischemia-3 reperfusion injury and left ventricular (LV) remodeling following a myocardial infarction 4 (MI) [1, 2] . In particular, reactive oxygen species (ROS) oxidize cellular components [3] , 5 leading to cardiomyocyte contractile dysfunction, myocyte apoptosis or cardiac hypertrophy 6 [4, 5] . 7
Myeloperoxidase (MPO; EC 1.11.2.2) is a member of the heme peroxidase 8 superfamily, synthesized by neutrophils, monocytes and macrophages, stored in their 9 azurophilic granules and released in substantial amount upon leukocyte activation [6] . MPO 10 has beneficial effects in the innate host defense mechanisms [7] . Considerable evidence has 11 emerged to suggest, that ROS formation by MPO promotes various deleterious action in the 12 cardiovascular (CV) system and contributes to the development of CV diseases [6] . 13 Individuals with a total or subtotal MPO deficiency (a defect with a frequency of ≈1 in every 14 2000 to 4000 Caucasians) are protected from CV diseases [6] . An elevated level of 15 circulating MPO is a prognostic marker of mortality and predicts the risks of subsequent 16 major adverse cardiac events in patients with acute coronary syndrome (ACS) [8] , 17 particularly in association with a low LV ejection fraction [9] . MPO also contributes to 18 adverse LV remodeling after a MI [10] . MPO exerts adverse effects on the vasculature, 19 oxidizes low-density lipoprotein (LDL) [11] , impairs the high-density lipoprotein (HDL) 20 function [12] and reduces the bioavailability of nitric oxide (NO) [13] . MPO can therefore 21 serve as a valuable biomarker of inflammation in coronary artery disease (CAD) and ACS 22 [14] . The serum level of MPO correlates positively with the severity of the LV dysfunction 23 and seems to be an essential factor in the development and exacerbation of heart failure (HF) 24 [15, 16] . Interestingly, the MPO concentration was earlier found not to differ in ischemic and 25
Protein SH oxidation 1
Cardiomyocytes were isolated from LV myocardial samples (25 mg wet weight) similarly as 2 for the functional measurements, and were treated in Iso (150 µl) containing H 2 O 2 (30 µM) or 3 MPO+H 2 O 2 (38 U/l) for 15 min. Cardiomyocytes exposed to dithiodipyridine (DTDP, 2.5 4 mM, for 2 min) were used as positive control. Protein SH groups were labeled with EZ-Link 5
Iodoacetyl-LC-Biotin (Thermo Scientific, Rockford, IL, USA, for 60 min in the dark, at room 6 temperature) in a reaction buffer (containing EDTA 5 mM, Tris-HCl 50 mM pH 8.3 and 0.1 7 mg/ml biotin) according to the manufacturer's instructions (biotin was solved in 8 dimethilformamide (DMF, Sigma-Aldrich, St. Louis, MO, USA) and diluted in reaction 9 buffer to 0.1 mg/ml). After the biotinylation process, the myocytes were solubilized in sample 10 buffer (containing 8 M urea, 2 M thiourea, 3% (w/v) sodium dodecyl sulphate (SDS), 75 mM 11 DTT, Tris-HCl pH 6.8, 10% (v/v) glycerol, bromophenol blue, 10 µM E-64 and 40 µM 12 leupeptin (1 h, under continuous agitation). Protein concentration was determined in the 13 supernatant with a dot-blot-based method, using bovine serum albumin (BSA, Sigma-14 Aldrich, St. Louis, MO, USA) as a standard. Protein concentration was adjusted to 1 mg/ml. 15 2% (strengthened with 0.5% agarose), 4%, 10% and 15% polyacrylamide gels and 4-15% 16 gradient gels (BioRad, Hercules, CA, USA) were used to separate myofilament proteins 17 before blotting to nitrocellulose membranes. Protein was quantitated with the fluorescent 18 Sypro Ruby Protein Blot Stain (Invitrogen, Eugene, OR, USA). Membranes were blocked 19 with 10% (w/v) milk powder diluted in PBS containing 0.1% (v/v) Tween-20 (PBST). 20
Biotin-labeled SH groups were probed with peroxidise-conjugated streptavidin (Jackson 21
ImmunoResearch, West Grove, PA, USA) at a final concentration of 5 ng/ml for 30 min. 22
Signal intensities of biotin-labeled SH groups were visualized by an enhanced 23 chemiluminescence (ECL) method and normalized for those assessed with the Sypro Ruby 24
Protein Blot Stain. 25
Protein disulfide cross-bridge formation 1
Similarly to the experiments by Canton et al. [45] human LV myocardial samples were 2 solubilized in reducing (1x Laemmli sample buffer (Sigma-Aldrich, St. Louis, MO, USA) 3 containing 2% SDS, 10% glycerol, 5% β-mercaptoethanol (β-ME), 0.0625 M Tris-HCl, pH 4 6.8) and non-reducing (same buffer without β-ME) sample buffer after H 2 O 2 or MPO+H 2 O 2 5 treatment. SDS-PAGE was performed using 10% polyacrylamide gels, thereafter proteins 6 were transferred onto nitrocellulose membranes. After blocking the non-specific binding sites 7 membranes were probed with monoclonal anti-tropomyosin (1:10.000, clone CH1) or 8 Western immunoblot assays were performed in triplicates. Intensities of protein bands 5 were quantified by determining the area under intensity curves by a Gaussian fit using ImageJ 6 (NIH, Bethesda, MD, USA) and Magic Plot (Saint Petersburg, Russia) software. Graphs were 7 created in GraphPad Prism 5.0 software. 8
Differences between groups were calculated by analysis of variance (ANOVA 9 followed by Bonferroni's post hoc test) or multilevel mixed-effects linear regression analysis, 10 to appropriately address non-independence between multiple observations from the same 11 heart. The null hypothesis for all group means being equal was tested, followed by pairwise 12 between-groups comparisons based on the variance-covariance matrix of the fixed effects. 13
Comparisons of normalized pCa-force relationships determined upon subsequent applications 14 of the agents were performed with paired and unpaired t tests. Group descriptions were based 15 on the mean and SEM values. Statistical significance was accepted at p < 0.05. 16 (pCa 9.0) F passive were observed (to 57.7±4.1% and 179.6±14.6% of untreated, respectively, 7 n=12) (Fig. 1B) 
Met inhibits the chlorinating, but not the peroxidase activity of MPO 23
To identify the biochemical mechanism underlying the functional effects of MPO, we 24 measured its chlorinating and peroxidase activities in the presence of the MPO-I and Met 25 ( Fig. 2A, B) . The MPO-I diminished both the chlorinating and the peroxidase activities of 1 MPO (to 0.3±0.2% and 10.4±6.0%, respectively, p<0.001, n=4). However, Met selectively 2 inhibited the chlorinating activity of MPO (to 2.3±1.3%, p<0.001, n=4), without significantly 3 affecting on its peroxidase activity (78.4±8.6%, n=4). 4 5
MPO-I and Met completely prevent, while DTT partially reverses the MPO-induced 6 cardiomyocyte dysfunction 7
To assess whether the MPO-I or Met is also able to prevent the deleterious mechanical effects 8 of MPO, cardiomyocytes were incubated with MPO+H 2 O 2 in the presence of the MPO-I (50 9 μM) or Met (10 mM). Both the MPO-I and Met prevented the MPO-induced decrease in 10 F active (to 80.0±5.3% and 80.1±3.6% of untreated, respectively, p<0.001) (Fig. 3A) (Fig.  12   4B ). In contrast, the SH contents of myosin-binding protein C (MyBP-C, Fig. 4C ) and the 13 more compliant (N2BA) and stiffer (N2B) isoforms of the giant sarcomeric protein titin were 14 not affected by these treatments (Fig. 4D-F μM and 50 μM) induced a significant rise in F passive of skinned rat trabeculae [48] . It is well 6 established that the giant sarcomeric protein titin plays a key role in the development of 7 F passive in permeabilized cardiomyocytes by acting as a molecular spring in the sarcomere 8
[49]. The cardiomyocyte F passive can be modulated by the titin isoform switch (between the 9 short and stiff N2B and the longer and more compliant N2BA isoforms [50] ) and by several 10 post-translational modifications, including phosphorylation [51], SH oxidation [52] and 11 potentially carbonylation. One elegant study demonstrated that the oxidative stress-induced 12 formation of disulfide bridges within the titin molecule (N2B unique sequence, N2B-Us) 13 reduced the contour length of the N2B-Us, leading to stiffening of the whole titin molecule 14 [52] . In the present study, neither SH oxidation nor carbonylation of the N2B and N2BA titin 15 isoforms was found to be affected by MPO or H 2 O 2 treatment. This may be explained by the 16 distinct sensitivities of the titin N2B isoform, actin and MyBP-C to oxidative changes based 17 on the differences in their ultrastructures and SH group contents. Our results indicate that 18 modifications other than titin SH oxidation or carbonylation might be responsible for the 19 marked elevation in F passive after MPO treatment in human cardiomyocytes. 20
The significant decrease observed in pCa 50 after MPO+H 2 O 2 in this study is in marked 21 contrast with the previous finding of an increase in pCa 50 in skinned rat trabeculae in 22 response to HOCl treatment [48] . This apparently conflicting result might be explained by (1) The extent of overall SH oxidation observed after MPO treatment in this study was 3 comparable to that in heart tissue slices exposed to high-dose HOCl [27] . There is 4 biochemical evidence that oxidative modifications modulate the architecture of the 5 myofilament protein actin [61] and myosin [62] . In vitro exposure of permeabilized human 6 LV cardiomyocytes to the oxidative agent DTDP resulted in a decrease in maximal Ca 2+ -7 activated force production with a parallel reduction in the SH content of actin and MLC-1 8
[26]. Consistent with this, in the present study H 2 O 2 decreased the SH content of actin. 9
However, despite the marked reduction in F active , no additional decrease in this parameter was 10 detected after MPO+H 2 O 2 application, suggesting that SH oxidation may not be the main 11 contributor to the MPO-evoked decrease in F active under these experimental conditions. 12
Moreover, formation of an actin and a Tm containing protein complex observed in this study 13 is also unlikely to be responsible for the contractile changes observed in the cardiomyocytes In this study LV heart samples were frozen and their functional and biochemical 7 properties were evaluated upon thawing. To validate the use of defrosted biopsy samples, in 8 one of our previous studies [67] force recordings of cardiomyocytes isolated from a biopsy 9 sample immediately after procurement were compared to those of cardiomyocytes isolated 10 from a defrosted biopsy of the same patient. These force recordings yielded identical results. 11
In addition, the extent of tissue heterogeneity was also addressed in previous studies using 12 explanted hearts [68, 69] or surgically procured biopsies [70] . In these studies the variability 13 of force measurements of cardiomyocytes isolated from different portions of the heart was 14 always less than 5%. 
